Regulation of airway hyperresponsiveness by calcitonin gene-related peptide in allergen sensitized and challenged mice

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 8, 2002, Pages 1137-1144

  Dakhama, Azzeddine ^a   Kanehiro, Arihiko ^a   Mäkelä, Mika J ^a   Loader, Joan E ^a   Larsen, Gary L ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Airway hyperresponsiveness; Allergen; Calcitonin gene related peptide

Indexed keywords

ANTIBODY; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE ALPHA; CALCITONIN GENE RELATED PEPTIDE DERIVATIVE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CD29 ANTIBODY; INTERLEUKIN 5 ANTIBODY; METHACHOLINE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC INNERVATION; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EOSINOPHIL; MOUSE; NERVE PLEXUS; NEUROEPITHELIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REGULATORY MECHANISM; SUBMUCOSA; TISSUE LEVEL;

EID: 0037090416     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.8.2109058     Document Type: Article

References (51)

1. Neuropeptides in the respiratory tract. Part I
2. Neuropeptides in the respiratory tract. Part II
3. Sensory neuropeptides and airway function
4. Sensory neuropeptides and the human lower airways: Present state and future directions
5. Mechanisms of activation of the sensory irritant receptor by airborne chemicals
6. 2a in the airways of human subjects
7. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma
8. Effects of tachykinins on mucus secretion on human bronchi in vitro
9. Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea pig
10. Neurogenic inflammation in the rat trachea. II. Identity and distribution of nerves mediating the increase in vascular permeability
11. 1 is inadequately explained by current models of lipid remodeling
12. Neuropeptides modulate human eosinophils chemotaxis
13. Substance P: A late-acting B lymphocyte differentiation cofactor
14. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
15. Immunomodulation by tachykinin neuropeptides
16. Coexistence of substance P and calcitonin gene-related peptide immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin
17. Sensory nerves containing tachykinins and CGRP in the lower airways. Functional implications for bronchoconstriction, vasodilation and protein extravasation
18. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
19. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
20. Calcitonin gene-related peptide is a potent vasodilator
21. The effects of calcitonin gene-related peptide on submucosal gland secretion and epithelial albumin transport on ferret trachea in vitro
22. Calcitonin gene-related peptide is localized to human airway nerves and potently constricts human airway smooth muscle
23. Specific receptors and cardiovascular effects of calcitonin gene-related peptide
24. Capsaicin-induced bronchoconstriction and neuropeptide release in guinea pig perfused lungs
25. Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways
26. Occurrence, distribution and ontogeny of CGRP immunoreactivity in the rat lower respiratory tract: Effect of capsaicin treatment and surgical denervations
27. Morphology and cytochemistry of the endocrine epithelial system in the lung
28. Nerve fibres containing calcitonin gene-related peptide in the mammalian respiratory tract and middle ear
29. Calcitonin gene-related peptide immunoreactivity in adult mouse lung
30. Evidence for a role of the integrin VLA-4 in lymphohemopoiesis
31. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent
32. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice
33. Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice
34. Airway response to electrical field stimulation in sensitized inbred mice: Passive transfer of increased responsiveness with peribronchial lymph nodes
35. Increased acetylcholine release in tracheas from allergen-exposed IgE-immune mice
36. Molecular and cellular mechanisms of allergic disease
37. Eosinophil trafficking in asthma
38. Pretreatment with antibody to eosinophil major protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs
39. Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein
40. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation
41. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation
42. Degradation of airway neuropeptides by human lung tryptase
43. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide
44. Characterization of CGRP1 and CGRP2 receptor subtypes
45. Pharmacology of receptors for calcitonin gene-related peptide and amylin
46. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors
47. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity
48. hCGRPS-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery
49. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
50. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin
51. Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator